GlassScriptPhysician profile
Cheng-Lun Soo
NPI 1013912617
$327,286.61
in general payments reported to CMS, 2019-2025
29 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178K · 2020: $4,515 · 2021: $78K · 2022: $13K · 2023: $42K · 2024: $12K · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $27K · Consulting Fee: $23K · Food and Beverage: $1,868 · Travel and Lodging: $1,622 · Gift: $362 · Entertainment: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $27,129.38 |
| Consulting Fee | $23,149.99 |
| Food and Beverage | $1,867.65 |
| Travel and Lodging | $1,622.08 |
| Gift | $362.14 |
| Entertainment | $245.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $171,674.71 | 2019-2020 | |
| Medtronic, INC. | $67,668.28 | 2021-2023 | Intellis Adaptivestim, Accurian |
| Flospine LLC | $43,812.28 | 2021-2024 | Panama Anterior Cervical Plate System, Keylift Interlaminar Expandable System |
| Si-Bone, INC. | $27,220.03 | 2019-2025 | |
| Nexus Spine, LLC | $9,277.69 | 2022-2024 | Presson |
| Alevio, LLC | $4,000.00 | 2019 | |
| Alphatec Spine, INC | $1,677.90 | 2019 | |
| Forte Bio-Pharma LLC | $490.38 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Relievant Medsystems, INC. | $472.13 | 2019 | |
| Globus Medical, INC. | $171.79 | 2021-2025 | Senza, Colosseum |
| Providence Medical Technology, INC. | $149.59 | 2019-2023 | |
| Sentynl Therapeutics, INC. | $81.44 | 2019 | |
| Abbott Laboratories | $79.59 | 2019-2021 | |
| Nevro Corp. | $69.29 | 2020-2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $60.02 | 2024-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nanohive Medical LLC | $59.86 | 2025 | Tlif |
| Radius Health, INC. | $54.41 | 2019-2021 | |
| Prosidyan, INC | $37.29 | 2019 | |
| Bioventus LLC | $32.68 | 2022-2023 | Bonescalpel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.83 | 2024 | Relistor |
| Centinel Spine, LLC | $26.28 | 2023 | Prodisc C Vivo |
| Vertiflex, INC. | $26.20 | 2019 | |
| Zyla Life Sciences, INC. | $24.77 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $23.01 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $19.98 | 2021 | |
| Stimwave Technologies Incorporated | $17.49 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.75 | 2024 | Exparel, Zilretta, Iovera |
| Ibsa Pharma INC. | $14.94 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$179,273.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheng-Lun Soo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.